D
Transphorm, Inc. TGAN
$4.90 $0.010.20%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
D
Sell 1/11/2024Upgraded
Transphorm, Inc. (TGAN) was upgraded to D- from E+ on 1/11/2024 due to an increase in the volatility index.
E
Sell 4/4/2023Downgrade
Transphorm, Inc. (TGAN) was downgraded to E+ from D- on 4/4/2023 due to a decline in the total return index and volatility index.
D
Sell 3/14/2023Downgrade
Transphorm, Inc. (TGAN) was downgraded to D- from D on 3/14/2023 due to a large decline in the total return index, solvency index and growth index. EBIT declined 79.9% from -$5.5M to -$9.9M, operating cash flow declined 78.96% from -$4.9M to -$8.77M, and earnings per share declined from -$0.1059 to -$0.1844.
D
Sell 2/9/2023Upgraded
Transphorm, Inc. (TGAN) was upgraded to D from E+ on 2/9/2023 due to an increase in the volatility index.
E
Sell 2/8/2023Downgrade
Transphorm, Inc. (TGAN) was downgraded to E+ from D on 2/8/2023 due to a noticeable decline in the solvency index, total return index and volatility index. The quick ratio declined from 2.43 to 1.87, and debt to equity increased from 0.3 to 0.34.
D
Sell 5/16/2022Upgraded
Transphorm, Inc. (TGAN) was upgraded to D from E+ on 05/16/2022.
E
Sell 5/13/2022Downgrade
Transphorm, Inc. (TGAN) was downgraded to E+ from D on 5/13/2022 due to a decline in the total return index.
D
Sell 5/4/2022Upgraded
Transphorm, Inc. (TGAN) was upgraded to D from E+ on 05/04/2022.
E
Sell 5/1/2022Downgrade
Transphorm, Inc. (TGAN) was downgraded to E+ from D on 5/1/2022 due to a decline in the total return index.
D
Sell 4/21/2022Upgraded
Transphorm, Inc. (TGAN) was upgraded to D from E+ on 4/21/2022 due to an increase in the total return index.
E
Sell 4/20/2022Downgrade
Transphorm, Inc. (TGAN) was downgraded to E+ from D on 4/20/2022 due to a major decline in the growth index and valuation index. EBIT declined 221.2% from $3.93M to -$4.77M, earnings per share declined from $0.14 to -$0.0847, and total revenue declined 59.27% from $11.3M to $4.6M.
D
Sell 11/18/2021Upgraded
Transphorm, Inc. (TGAN) was upgraded to D from D- on 11/18/2021 due to a major increase in the growth index, total return index and volatility index. Total revenue increased 251.46% from $3.22M to $11.3M, EBIT increased 185.45% from -$4.6M to $3.93M, and earnings per share increased from -$0.1735 to $0.14.
D
Sell 11/3/2021Downgrade
Transphorm, Inc. (TGAN) was downgraded to D- from D on 11/3/2021 due to a decline in the volatility index.
D
Sell 10/8/2021Upgraded
Transphorm, Inc. (TGAN) was upgraded to D from D- on 10/8/2021 due to an increase in the volatility index and total return index.
D
Sell 8/18/2021Downgrade
Transphorm, Inc. (TGAN) was downgraded to D- from D on 8/18/2021 due to a decline in the growth index, total return index and solvency index. The quick ratio declined from 0.41 to 0.3, debt to equity increased from -1.45 to -1.2, and EBIT declined 1.43% from -$4.54M to -$4.6M.
D
Sell 8/2/2021Upgraded
Transphorm, Inc. (TGAN) was upgraded to D from D- on 8/2/2021 due to an increase in the valuation index.
D
Sell 4/1/2021Upgraded
Transphorm, Inc. (TGAN) was upgraded to D- from E on 4/1/2021 due to a major increase in the total return index, volatility index and growth index. Operating cash flow increased 55.3% from -$3.18M to -$1.42M, total revenue increased 4.35% from $1.93M to $2.01M, and earnings per share increased from -$0.1917 to -$0.1904.
E
Sell 1/4/2021Upgraded
Transphorm, Inc. (TGAN) was upgraded to E from E- on 1/4/2021 due to an increase in the total return index and solvency index.
E
Sell 10/21/2020None
Transphorm, Inc. (TGAN) was downgraded to E- from U on 10/21/2020.
Weiss Ratings